AG真人官方

Anghami Inc. (ANGH) filed a Form 6-K announcing a 1-for-10 reverse stock split of its ordinary shares to restore compliance with Nasdaq鈥檚 US$1.00 minimum bid rule. Shareholders approved the action at the 22 Jul 2025 EGM. The split will be effected after market close 1 Aug 2025; trading on a split-adjusted basis begins 4 Aug 2025 under the same ticker with new CUSIP G0369L200.

Key mechanics:

• Every ten shares consolidate into one; no shareholder action required.
• Par value rises proportionally from US$0.0001 to US$0.001.
• Strike and conversion prices of all outstanding convertibles/warrants will be adjusted 10脳 higher.
• No fractional shares issued; cash paid in lieu.

The company states the move will not dilute ownership but should elevate the post-split share price and preserve Nasdaq Capital Market listing.

Safe & Green Holdings Corp. (Nasdaq: SGBX) has filed Amendment No. 3 to its Form S-1 to register 20,408,160 common shares for resale by a single selling stockholder. The shares comprise 2,504,040 common shares and 17,904,120 shares underlying $0.0001 pre-funded warrants issued in an April 14 2025 private placement that generated roughly $8 million gross. The company will receive no proceeds from the resale, and only 鈮�$20,408 if all pre-funded warrants are exercised in cash; those funds and the April placement proceeds are earmarked for working capital.

SGBX remains a smaller reporting company and has faced repeated Nasdaq deficiencies. A July 8 2025 Hearings Panel decision allows continued listing provided the firm effects a reverse split (1-for-10 to 1-for-100) and sustains a 鈮�$1.00 bid for 10 consecutive days by Aug 28 2025. A shareholder vote is set for Aug 25 2025.

Liquidity moves in 2025: (i) $2 million secured revolver at 5% with Prosperity Bank; (ii) up to $100 million equity line with Generating Alpha Ltd.; (iii) $267 k OID note at 15% convertible on default; (iv) $1 million County Line and $1 million Sherman Oil asset purchases; (v) planned merger with New Asia Holdings to add 鈮�$35 million to equity. April Series A/B warrants were exchanged for 60,000 Series B preferred shares to ease Nasdaq dilution concerns.

Post-offering common shares outstanding, assuming full warrant exercise, would rise to 30,024,771 versus 12,120,651 currently, excluding additional options, warrants, RSUs and 300 million shares underlying Series B preferred.

Lazard (LAZ) Q2-25 10-Q highlights: Net revenue rose 16% YoY to $796 M on stronger Financial Advisory fees (+21% to $493 M) and modest Asset Management growth (+3% to $276 M). Operating expenses climbed 13% to $703 M, but the cost ratio improved, lifting operating income 46% to $93 M. Net income attributable to Lazard increased 11% to $55 M; diluted EPS advanced to $0.52 from $0.49.

Year-to-date (6 M): Net revenue was flat at $1.44 B, while tighter expenses trimmed the comp ratio and pushed net income up 36% to $116 M (EPS $1.08 vs $0.84).

Balance sheet & cash flow: Cash and cash equivalents fell to $978 M from $1.31 B at 12/31/24, reflecting negative operating cash flow of $168 M driven by incentive compensation payments and working-capital swings. Senior debt remained steady at $1.69 B. Shareholders鈥� equity improved 17% to $742 M due to earnings and lower treasury stock after share deliveries. Book value per share is roughly $7.57.

Key metrics: Q2 operating margin 11.7% (vs 9.3%); comp & benefits 65% of net revenue (vs 66%). Diluted share count rose 4% YoY to 104.9 M.

Renalytix plc (RNLX) filed Post-Effective Amendment No. 1 to its Form S-8 (Reg. No. 333-274732). The amendment terminates the effectiveness of the original registration statement and dere颅gisters all ordinary shares (拢0.0025 par value) that remain unissued under two employee programs: (1) the 2020 Employee Share Purchase Plan and (2) the 2020 Equity Incentive Plan. No new securities will be offered pursuant to these plans under this registration after the filing becomes effective, which occurs automatically upon submission under Rule 464.

The company confirms its status as a non-accelerated filer, smaller reporting company, and emerging growth company. The document is signed by CEO James McCullough in London on 25 July 2025, with no additional signatures required under Rule 478.

OSN Streaming Limited and affiliated entities filed Amendment No. 6 to Schedule 13D for Anghami Inc. ("ANGH"). The group now beneficially owns 72,411,753 ordinary shares, or 70.8% of Anghami鈥檚 outstanding stock. The stake is comprised of 36.99 M shares held outright, 13.43 M shares issuable from warrants exercisable at $11.50, and 22 M shares issuable upon conversion of three notes at $2.50.

On 17 & 21 Jul 2025 the group elected to purchase an additional US$23 M convertible note (鈥淭hird Note鈥�) under the existing Note Purchase Agreement, bringing total convertible debt acquired to US$55 M (Initial $12 M, Second $20 M, Third $23 M). The Third Note is expected to be issued on or about 24 Jul 2025 and carries the same $2.50 conversion price, further increasing potential dilution.

The filing restates ownership calculations based on a fully-diluted 102.3 M share count and references a March 2025 SPA that could sell up to 33.83% of OSN Streaming to a purchaser, accompanied by shareholder and option agreements regulating future governance.

Local Bounti Corporation (LOCL) has filed a Form 144 disclosing a planned disposition of restricted stock under Rule 144 of the Securities Act.

Seller: KEBS Trust
Planned sale: 3,500 common shares
Broker: Morgan Stanley Smith Barney, New York
Approximate sale date: 10 July 2025 (on the NYSE)
Aggregate market value: $9,261.35
Shares outstanding: 10,914,704
This transaction equals roughly 0.03 % of the company鈥檚 outstanding stock, indicating minimal dilution risk.

The shares were originally received as a gift from an affiliate on 28 December 2022. KEBS Trust has already executed several open-market sales in the past three months:

• 09 Jul 2025 鈥� 200 shares 鈥� $602.00
• 22 May 2025 鈥� 1,179 shares 鈥� $2,458.33
• 21 May 2025 鈥� 600 shares 鈥� $1,262.52
• 20 May 2025 鈥� 800 shares 鈥� $1,736.72
• 19 May 2025 鈥� 1,000 shares 鈥� $2,226.60
• 16 May 2025 鈥� 1,421 shares 鈥� $3,326.13

Total prior 3-month sales: 5,200 shares for gross proceeds of about $11,612. The signatory affirms no undisclosed adverse information and acknowledges SEC anti-fraud provisions.